DOCSLIB.ORG

Surgery and Healing in the Developing World

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Surgery and Healing in the Developing World Glenn W. Geelhoed, M.D., FACS Professor of Surgery Professor of International Medical Education Professor of Microbiology and Tropical Medicine George Washington University Medical Center Washington, D.C., U.S.A. L A N D E S B I O S C I E N C E GEORGETOWN, TEXAS U.S.A. Surgery and Healing in the Developing World LANDES BIOSCIENCE Georgetown, Texas U.S.A. 2005 Landes Bioscience Printed in the U.S.A. Please address all inquiries to the Publisher: Landes Bioscience, 810 S. Church Street, Georgetown, Texas, U.S.A. 78626 Phone: 512/ 863 7762; FAX: 512/ 863 0081 While the authors, editors, sponsor and publisher believe that drug selection and dosage and the specifications and usage of equipment and devices, as set forth in this book, are in accord with current recommendations and practice at the time of publication, they make no warranty, expressed or implied, with respect to material described in this book. In view of the ongoing research, equipment development, changes in governmental regulations and the rapid accumulation of information relating to the biomedical sciences, the reader is urged to carefully review and evaluate the information provided herein. Contents Foreword .......................................................................... ix Preface.............................................................................. xi 1. Preparation Time .............................................................. 1 Harvey Bratt 2. Surgery in Developing Countries ...................................... 6 John E. Woods 3. A Commitment to Voluntary Health Care Service .......... 13 Donald C. Mullen 4. International Surgical Education: The Perspective from Several Continents ........................ 18 Glenn W. Geelhoed 5. Medicine Writ Large in the Raw, without Power or Plumbing ............................................ 25 Glenn W. Geelhoed 6. To My Son, the Urologist ................................................ 33 Douglas Walter Soderdahl and Douglas Wayne Soderdahl 7. Medicine and Surgery in the Third World ...................... 53 Lawrence Levy 8. Lab in a Suitcase ............................................................. 59 Christine A. King and James Kerr 9. Lab-in-a-Suitcase: Saving Lives in Remote Corners of the Globe .................................................................... 68 Hollee D. Van der Veen and Milton B. Amanyun 10. Establishing Electrical Power in Remote Facilities for Health Care ............................................................... 71 Jeffrey A. Mazer 11. Tropical Nursing ............................................................. 87 Diana Downing 12. Communication in the Third World: A One-Way Street............................................................ 92 Jim Bascom 13. Anesthesia in the Third World ........................................ 98 John F. Williams 14. Outpatient Assessment of the Pregnant Patient: Dilatation and Curettage .............................................. 109 Kedrick D. Pickering 15. Basic Obstetrics and Obstetric Surgery in a Mission Setting ...................................................... 118 F. L. Dutton and Glenn W. Geelhoed 16. Pointers for American Surgeons Going to the Developing World ............................................... 144 Donald E. Meier and John L. Tarpley 17. Training to Serve the Unmet Surgical Needs Worldwide .......................................................... 153 Robert J. W. Blanchard, Ronald C. Merrell, Glenn W. Geelhoed, Olajide O. Ajayi, Donald R. Laub and Edgar Rodas 18. Guide to the Operating Theater on $25 a Patient ......... 167 Glenn P. Verbrugge 19. Orthopedic Surgery ...................................................... 177 Richard C. Fisher 20. Chronic Pyogenic Osteomyelitis in a Rural Area: The Aggravating Factor of Underdevelopment.............. 186 Ahuka Ona Longombe 21. Study of the Epidemiology and Treatment of Fractures in Rural North-East of Democratic Republic of Congo ....................................................................... 191 Ahuka Ona Longombe, M. Mbusa, K. Diyo, M. Kakule, K. Kasindi and M. Duani 22. The Prevention and Treatment of Landmine Injuries in the Developing World ............................................... 195 James C. Cobey 23. Cleft Lip and Palate Surgery in Developing Countries ............................................... 200 William P. Magee 24. Outreach Dentistry: A World of Wonder Awaits in the Golden Anniversary of General Dentistry ........... 218 Glenn W. Geelhoed 25. Dentistry ....................................................................... 233 David Foskett and Anthony M. Vandersteen 26. Reconstructive Surgery in the Tropics........................... 243 Harold P. Adolph 27. Factors Influencing Geographic Distribution and Incidence of Tropical Surgical Diseases .................. 277 Ricardo Cohen, Frederico Aun and Glenn W. Geelhoed 28. Population Dynamics of Surgical Tropical Diseases...... 285 Ricardo Cohen, Frederico Aun, Glenn W. Geelhoed and Eric L. Sarin 29. Metabolic Maladaptation .............................................. 288 Glenn W. Geelhoed 30. Nutrition and Development in Africa Risk: Factors on Either Side of the Fulcrum Balance ............. 321 Glenn W. Geelhoed 31. Uterine Ruptures in Rural Zaire ................................... 325 Ahuka Ona Longombe, K.M. Lusi and P. Nickson 32. Vesicovaginal Fistula of Obstetrical Origin in Northeast Democratic Republic of Congo (DRC): The Experience of the CME Nyankunde....................... 331 Ahuka Ona Longombe 33. Ophthalmology ............................................................. 335 James Kerr and Christine A. King 34. Accommodating Deficits in Material and Assistance ............................................................... 348 William L. Barrett, Laji Varghese and Malini Anand 35. Abscesses and Other Infections Treated by Surgery....... 358 Robert J. W. Blanchard 36. Surgical Training of Nurses for Rural Areas: Necessity or Aberration?................................................ 379 Ahuka Ona Longombe 37. Training of Medical Assitants in Mozambique for Surgery in a Rural Setting ....................................... 386 Ivo Paulo Garrido 38. Training Surgeons in the Developing World ................. 389 David C. Thompson 39. Mobile Surgery ............................................................. 404 Edgar Rodas and Edgar B. Rodas 40. Public Health Problems on Burma Frontiers: A Window into a Nation in Crisis ................................. 411 Myaing Nyunt 41. Medical Adventures in the Nigerian Bush ..................... 418 Glenn W. Geelhoed and Sally E. Geelhoed 42. Infectious Disease Mortality ......................................... 419 Glenn Geelhoed 43. World Health ................................................................ 438 Glenn W. Geelhoed ................................................................................. 44. Treating Others: Human Sciences in Theory and Practice ....................... 441 Glenn W. Geelhoed 45. The Impact of a Volunteer Medical Mission on the Attitudes, Knowledge Base, and Reported Humanitarian Motivations of a Group of Medical and Public Health Students .......................................... 447 Glenn W. Geelhoed 46. Field Notes on the Clinical, Public Health, Geographic, and Political Features of a Typical Day in a Himalayan Medical Mission .................................. 461 Glenn W. Geelhoed Editor Glenn W. Geelhoed, M.D., FACS Professor of Surgery Professor of International Medical Education Professor of Microbiology and Tropical Medicine George Washington University Medical Center Washington, D.C., U.S.A. Email: [email protected] Chapters Preface, 4, 5, 15, 17, 24, 27, 28-30, 41-46 Contributors Harold P. Adolph Diana Downing Chapter 26 Chapter 11 Olajide O. Ajayi M. Duani Chapter 17 Chapter 21 Milton B. Amanyun F. L. Dutton Chapter 9 Chapter 15 Malini Anand Richard C. Fisher Chapter 34 Chapter 19 Frederico Aun David Foskett Chapters 27, 28 Chapter 22 William L. Barrett Ivo Paulo Garrido Chapter 34 Chapter 37 Jim Bascom Glenn W. Geelhoed Chapter 12 Chapters Preface, 4, 5, 15, 17, 24, 27, 28-30, 41-44 Robert J. W. Blanchard Chapters 17, 35 Sally E. Geelhoed Chapter 41 Harvey Bratt Chapter 1 M. Kakule Chapter 21 James C. Cobey Chapter 22 K. Kasindi Chapter 21 Ricardo Cohen Chapters 27, 28 James Kerr Chapters 8, 33 K. Diyo Chapter 21 Christine A. King Chapters 8, 33 Donald R. Laub Edgar Rodas Chapter 17 Chapters 17, 39 Lawrence Levy Edgar B. Rodas Chapter 7 Chapter 39 Ahuka Ona Longombe Eric L. Sarin Chapters 20, 21, 31, 32, 35, 36 Chapter 28 K.M. Lusi Douglas Walter Soderdahl Chapter 31 Chapter 6 William P. Magee Douglas Wayne Soderdahl Chapter 21 Chapter 6 Jeffrey A. Mazer John L. Tarpley Chapter 10 Chapter 16 M. Mbusa David C. Thompson Chapter 21 Chapter 38 Donald E. Meier Hollee D. Vander Veen Chapter 16 Chapter 9 Ronald C. Merrell Anthony M. Vandersteen Chapter 17 Chapter 25 Donald C. Mullen Laji Varghese Chapter 3 Chapter 34 P. Nickson Glenn P. Verbrugge Chapter 31 Chapter 18 Myaing Nyunt John F. Williams Chapter 40 Chapter 13 Kedrick D. Pickering John E. Woods Chapter 14 Chapter 2 Foreword Surgery and Healing in the Developing World The major thrust of this book is to present a collection of “how I do it” from 50 authors. The whole book is a valuable traveling companion for those attempting their first medical mission, or veterans of many such trips eager to better perform this art. There is an occasional familiar
Recommended publications
  • TOOLS and EQUIPMENT Orthotic 561

    TOOLS and EQUIPMENT Orthotic 561

    TOOLS AND EQUIPMENT Orthotic 561 Tools Shoe Stretchers............................562 Brannock Measuring Device..................562 Mixing Bowls ..............................562 Aluminum Cast Mandrels ....................562 Laminating Fixtures.........................563 Vises and Yates Clamps.................563-564 Measuring Devices .....................564-567 Hex Sets and Balldrivers.................567-569 Screw and Drill Gages ......................569 Cutting Nippers ............................570 Plastering Tools............................571 Shears and Scissors ....................571-572 Blades, Knives and Surforms .............572-575 Rivets, Punch Sets and Eyelets ...........576-579 Reamers .................................579 Needle Kit ................................579 Deburring Tool.............................579 Rout-A-Burr ...............................579 Precision Oiler.............................580 Countersinks ..............................580 Adjustable Bits.............................580 Tools Ball Set Tool . 580 Micro Torches and Heat Guns ............580-582 Cast Spreaders and Cutters ..............583-584 Alignment Fixtures .........................584 Benders and Contouring Iron .............584-585 Equipment Carvers, Cutters and Routers.............585-588 Sanding Accessories............ 589-591, 601-603 Sewing and Patching Machines ...............592 Drill Press ................................593 Band Saws . .594-595 Dust Collectors ........................596-597
  • Updates in Uterine and Vulvar Cancer

    Updates in Uterine and Vulvar Cancer

    Management of GYN Malignancies Junzo Chino MD Duke Cancer Center ASTRO Refresher 2015 Disclosures • None Learning Objectives • Review the diagnosis, workup, and management of: – Cervical Cancers – Uterine Cancers – Vulvar Cancers Cervical Cancer Cervical Cancer • 3rd most common malignancy in the World • 2nd most common malignancy in women • The Leading cause of cancer deaths in women for the developing world • In the US however… – 12th most common malignancy in women – Underserved populations disproportionately affected > 6 million lives saved by the Pap Test “Diagnosis of Uterine Cancer by the Vaginal Smear” Published Pap Test • Start screening within 3 years of onset of sexual activity, or at age 21 • Annual testing till age 30 • If no history of abnormal paps, risk factors, reduce screening to Q2-3 years. • Stop at 65-70 years • 5-7% of all pap tests are abnormal – Majority are ASCUS Pap-test Interpretation • ASCUS or LSIL –> reflex HPV -> If HPV + then Colposcopy, If – Repeat in 1 year • HSIL -> Colposcopy • Cannot diagnose cancer on Pap test alone CIN • CIN 1 – low grade dysplasia confined to the basal 1/3 of epithelium – HPV negative: repeat cytology at 12 months – HPV positive: Colposcopy • CIN 2-3 – 2/3 or greater of the epithelial thickness – Cold Knife Cone or LEEP • CIS – full thickness involvement. – Cold Knife Cone or LEEP Epidemiology • 12,900 women expected to be diagnosed in 2015 – 4,100 deaths due to disease • Median Age at diagnosis 48 years Cancer Statistics, ACS 2015 Risk Factors: Cervical Cancer • Early onset sexual activity • Multiple sexual partners • Hx of STDs • Multiple pregnancy • Immune suppression (s/p transplant, HIV) • Tobacco HPV • The human papilloma virus is a double stranded DNA virus • The most common oncogenic strains are 16, 18, 31, 33 and 45.
  • Management of Specific Wounds

    Management of Specific Wounds

    7 Management of Specific Wounds Bite Wounds 174 Hygroma 234 Burns 183 Snakebite 239 Inhalation Injuries 195 Brown Recluse Spider Bites 240 Chemical Burns 196 Porcupine Quills 240 Electrical Injuries 197 Lower Extremity Shearing Wounds 243 Radiation Injuries 201 Plate 10: Pipe Insulation Protective Frostbite 204 Device: Elbow 248 Projectile Injuries 205 Plate 11: Pipe Insulation to Protect Explosive Munitions: Ballistic, the Greater Trochanter 250 Blast, and Thermal Injuries 227 Plate 12: Vacuum Drain Impalement Injuries 227 Management of Elbow Pressure Ulcers 228 Hygromas 252 Atlas of Small Animal Wound Management and Reconstructive Surgery, Fourth Edition. Michael M. Pavletic. © 2018 John Wiley & Sons, Inc. Published 2018 by John Wiley & Sons, Inc. Companion website: www.wiley.com/go/pavletic/atlas 173 174 Atlas of Small Animal Wound Management and Reconstructive Surgery BITE WOUNDS to the skin. Wounds may be covered by a thick hair coat and go unrecognized. The skin and underlying Introduction issues can be lacerated, stretched, crushed, and avulsed. Circulatory compromise from the division of vessels and compromise to collateral vascular channels can result in Bite wounds are among the most serious injuries seen in massive tissue necrosis. It may take several days before small animal practice, and can account for 10–15% of all the severity of tissue loss becomes evident. All bites veterinary trauma cases. The canine teeth are designed are considered contaminated wounds: the presence of for tissue penetration, the incisors for grasping, and the bacteria in the face of vascular compromise can precipi- molars/premolars for shearing tissue. The curved canine tate massive infection. teeth of large dogs are capable of deep penetration, whereas the smaller, straighter canine teeth of domestic cats can penetrate directly into tissues, leaving a rela- tively small cutaneous hole.

  • Family Medicine 2004

    Current Clinical Strate- gies Family Medicine Year 2004 Edition Paul D. Chan, MD Christopher R. Winkle, MD Peter J. Winkle, MD Current Clinical Strategies Publishing www.ccspublishing.com/ccs Digital Book and Updates Purchasers of this book can download the Palm, Pocket PC, Windows CE, Windows or Macintosh version and updates at the Current Clinical Strategies Publishing web site: www.ccspublishing.com/ccs/fm.htm. Copyright © 2004 Current Clinical Strategies Publishing. All rights reserved. This book, or any parts thereof, may not be reproduced or stored in an information retrieval network without the written permission of the publisher. The reader is advised to consult the package insert and other references before using any therapeutic agent. The publisher disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any of the contents of this text. Current Clinical Strategies Publishing 27071 Cabot Road Laguna Hills, California 92653 Phone: 800-331-8227; 949-348-8404 Fax: 800-965-9420; 949-348-8405 Internet: www.ccspublishing.com/ccs E-mail: [email protected] Printed in USA ISBN 1929622-36-8 INTERNAL MEDICINE Medical Documentation History and Physical Examination Identifying Data: Patient's name; age, race, sex. List the patient’s significant medical problems. Name of infor- mant (patient, relative). Chief Compliant: Reason given by patient for seeking medical care and the duration of the symptom. List all of the patients medical problems. History of Present Illness (HPI): Describe the course of the patient's illness, including when it began, character of the symptoms, location where the symptoms began; aggravating or alleviating factors; pertinent positives and negatives.
  • Reconstructive

    Reconstructive

    RECONSTRUCTIVE Muscle versus Nonmuscle Flaps in the Reconstruction of Chronic Osteomyelitis Defects Christopher J. Salgado, Background: Surgical treatment of chronic osteomyelitis requires aggressive M.D. debridement followed by wound coverage and obliteration of dead space with Samir Mardini, M.D. vascularized tissue. Controversy remains as to the effectiveness of different tissue Amir A. Jamali, M.D. types in achieving these goals and in the eradication of disease. Juan Ortiz, M.D. Methods: Chronic osteomyelitis was induced in 26 goat tibias using Staphylo- Raoul Gonzales, D.V.M., coccus aureus as an infecting inoculum. In a single stage, debridement followed Ph.D. by reconstruction using either a muscle flap (n ϭ 13) or a fasciocutaneous flap Hung-Chi Chen, M.D. (n ϭ 13) was performed. Flap donor sites were closed primarily and antibiotics El Paso, Texas; Kaohsiung, Taiwan; were given for 5 days postoperatively. Daily clinical evaluation for 1 year was and Sacramento, Calif. performed and monthly radiographs were obtained for 9 months and 1 year after the reconstruction. Results: Twenty-five flaps survived completely, and one nonmuscle flap under- went partial flap loss following a period of venous congestion. There were no postoperative complications in the muscle flap group. Two goats (15 percent) in the nonmuscle group developed superficial wounds in the immediate post- operative period that resolved with conservative management. No limbs had recurrent osteomyelitis wounds at 1 year of clinical follow-up examination. Radiographic evidence of osteomyelitis was present in two goats (15 percent) in the muscle group and one goat (8 percent) in the nonmuscle group.
  • B.J.ZH.F.Panther Medical Equipment Co., Ltd. 北京派爾特醫療科技股份

    B.J.ZH.F.Panther Medical Equipment Co., Ltd. 北京派爾特醫療科技股份

    The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of B.J.ZH.F.Panther Medical Equipment Co., Ltd. 北京派爾特醫療科技股份有限公司 (the “Company”) (a joint stock company incorporated in the People’s Republic of China with limited liability) WARNING The publication of this Application Proof is required by The Stock Exchange of Hong Kong Limited (the “Stock Exchange”) and the Securities and Futures Commission (the “Commission”) solely for the purpose of providing information to the public in Hong Kong. This Application Proof is in draft form. The information contained in it is incomplete and is subject to change which can be material. By viewing this document, you acknowledge, accept and agree with the Company, its sole sponsor, advisors or members of the underwriting syndicate that: (a) this document is only for the purpose of providing information about the Company to the public in Hong Kong and not for any other purposes. No investment decision should be based on the information contained in this document; (b) the publication of this document or supplemental, revised or replacement pages on the Stock Exchange’s website does not give rise to any obligation of the Company, its sole sponsor, advisors or members of the underwriting syndicate to proceed with an offering in Hong Kong or any other jurisdiction.
  • Treating Cervical Cancer If You've Been Diagnosed with Cervical Cancer, Your Cancer Care Team Will Talk with You About Treatment Options

    Treating Cervical Cancer If You've Been Diagnosed with Cervical Cancer, Your Cancer Care Team Will Talk with You About Treatment Options

    cancer.org | 1.800.227.2345 Treating Cervical Cancer If you've been diagnosed with cervical cancer, your cancer care team will talk with you about treatment options. In choosing your treatment plan, you and your cancer care team will also take into account your age, your overall health, and your personal preferences. How is cervical cancer treated? Common types of treatments for cervical cancer include: ● Surgery for Cervical Cancer ● Radiation Therapy for Cervical Cancer ● Chemotherapy for Cervical Cancer ● Targeted Therapy for Cervical Cancer ● Immunotherapy for Cervical Cancer Common treatment approaches Depending on the type and stage of your cancer, you may need more than one type of treatment. For the earliest stages of cervical cancer, either surgery or radiation combined with chemo may be used. For later stages, radiation combined with chemo is usually the main treatment. Chemo (by itself) is often used to treat advanced cervical cancer. ● Treatment Options for Cervical Cancer, by Stage Who treats cervical cancer? Doctors on your cancer treatment team may include: 1 ____________________________________________________________________________________American Cancer Society cancer.org | 1.800.227.2345 ● A gynecologist: a doctor who treats diseases of the female reproductive system ● A gynecologic oncologist: a doctor who specializes in cancers of the female reproductive system who can perform surgery and prescribe chemotherapy and other medicines ● A radiation oncologist: a doctor who uses radiation to treat cancer ● A medical oncologist: a doctor who uses chemotherapy and other medicines to treat cancer Many other specialists may be involved in your care as well, including nurse practitioners, nurses, psychologists, social workers, rehabilitation specialists, and other health professionals.
  • Gtg-No-20B-Breech-Presentation.Pdf

    Gtg-No-20B-Breech-Presentation.Pdf

    Guideline No. 20b December 2006 THE MANAGEMENT OF BREECH PRESENTATION This is the third edition of the guideline originally published in 1999 and revised in 2001 under the same title. 1. Purpose and scope The aim of this guideline is to provide up-to-date information on methods of delivery for women with breech presentation. The scope is confined to decision making regarding the route of delivery and choice of various techniques used during delivery. It does not include antenatal or postnatal care. External cephalic version is the topic of a separate RCOG Green-top Guideline No. 20a: ECV and Reducing the Incidence of Breech Presentation. 2. Background The incidence of breech presentation decreases from about 20% at 28 weeks of gestation to 3–4% at term, as most babies turn spontaneously to the cephalic presentation. This appears to be an active process whereby a normally formed and active baby adopts the position of ‘best fit’ in a normal intrauterine space. Persistent breech presentation may be associated with abnormalities of the baby, the amniotic fluid volume, the placental localisation or the uterus. It may be due to an otherwise insignificant factor such as cornual placental position or it may apparently be due to chance. There is higher perinatal mortality and morbidity with breech than cephalic presentation, due principally to prematurity, congenital malformations and birth asphyxia or trauma.1,2 Caesarean section for breech presentation has been suggested as a way of reducing the associated perinatal problems2,3 and in many countries in Northern Europe and North America caesarean section has become the normal mode of breech delivery.
  • Vantage by Integra® Miltex® Surgical Instruments

    Vantage by Integra® Miltex® Surgical Instruments

    Vantage® by Integra® Miltex® Surgical Instruments Table of Contents Operating Scissors ................................................................................................................................. 4 Scissors ................................................................................................................................................ 5-6 Bandage Scissors .................................................................................................................................... 7 Dressing and Tissue Forceps ................................................................................................................. 8 Splinter Forceps ...................................................................................................................................... 9 Hemostatic Forceps......................................................................................................................... 10-12 of Contents Table Towel Clamps ......................................................................................................................................... 13 Tubing Forceps .......................................................................................................................................14 Sponge and Dressing Forceps ............................................................................................................. 15 Needle Holders .................................................................................................................................16-17
  • Postpartum Haemorrhage

    Postpartum Haemorrhage

    Guideline Postpartum Haemorrhage Immediate Actions Call for help and escalate as necessary Initiate fundal massage Focus on maternal resuscitation and identifying cause of bleeding Determine if placenta still in situ Tailor pharmacological management to causation and maternal condition (see orange box). Complete a SAS form when using carboprost. Pharmacological regimen (see flow sheet summary) Administer third stage medicines if not already done so. Administer ergometrine 0.25mg both IM and slow IV (contraindicated in hypertension) IF still bleeding: Administer tranexamic acid- 1g IV in 10mL via syringe driver set at 1mL/minute administered over 10 minutes OR as a slow push over 10 minutes. Administer carboprost 250micrograms (1mL) by deep intramuscular injection Administer loperamide 4mg PO to minimise the side-effect of diarrhoea Administer antiemetic ondansetron 4mg IV, if not already given Prophylaxis Once bleeding is controlled, administer misoprostol 600microg buccal and initiate an infusion of oxytocin 40IU in 1L Hartmann’s at a rate of 250mL/hr for 4 hours. Flow chart for management of PPH Carboprost Bakri Balloon Medicines Guide Ongoing postnatal management after a major PPH 1. Purpose This document outlines the guideline details for managing primary postpartum haemorrhage at the Women’s. Where processes differ between campuses, those that refer to the Sandringham campus are differentiated by pink italic text or have the heading Sandringham campus. For guidance on postnatal observations and care after a major PPH, please refer to the procedure ‘Postpartum Haemorrhage - Immediate and On-going Postnatal Care after Major PPH 2. Definitions Primary postpartum haemorrhage (PPH) is traditionally defined as blood loss greater than or equal to 500 mL, within 24 hours of the birth of a baby (1).
  • Chapter 12 Vaginal Breech Delivery

    Chapter 12 Vaginal Breech Delivery

    FOURTH EDITION OF THE ALARM INTERNATIONAL PROGRAM CHAPTER 12 VAGINAL BREECH DELIVERY Learning Objectives By the end of this chapter, the participant will: 1. List the selection criteria for an anticipated vaginal breech delivery. 2. Recall the appropriate steps and techniques for vaginal breech delivery. 3. Summarize the indications for and describe the procedure of external cephalic version (ECV). Definition When the buttocks or feet of the fetus enter the maternal pelvis before the head, the presentation is termed a breech presentation. Incidence Breech presentation affects 3% to 4% of all pregnant women reaching term; the earlier the gestation the higher the percentage of breech fetuses. Types of Breech Presentations Figure 1 - Frank breech Figure 2 - Complete breech Figure 3 - Footling breech In the frank breech, the legs may be extended against the trunk and the feet lying against the face. When the feet are alongside the buttocks in front of the abdomen, this is referred to as a complete breech. In the footling breech, one or both feet or knees may be prolapsed into the maternal vagina. Significance Breech presentation is associated with an increased frequency of perinatal mortality and morbidity due to prematurity, congenital anomalies (which occur in 6% of all breech presentations), and birth trauma and/or asphyxia. Vaginal Breech Delivery Chapter 12 – Page 1 FOURTH EDITION OF THE ALARM INTERNATIONAL PROGRAM External Cephalic Version External cephalic version (ECV) is a procedure in which a fetus is turned in utero by manipulation of the maternal abdomen from a non-cephalic to cephalic presentation. Diagnosis of non-vertex presentation Performing Leopold’s manoeuvres during each third trimester prenatal visit should enable the health care provider to make diagnosis in the majority of cases.
  • Ⅰ Obstetric Hemorrhage Safety Bundle Implementation in a Rural

    Ⅰ Obstetric Hemorrhage Safety Bundle Implementation in a Rural

    Obstetric Hemorrhage Safety Bundle Implementation in a Rural CAH Dale C Robinson MD,FACOG Chief Ob/Gyn Grande Ronde Hospital La Grande Oregon S Planning for and Responding to Obstetric Hemorrhage California Maternal Quality Care Collaborative Obstetric Hemorrhage Version 2.0 Task Force This project was supported by Title V funds received from the California Department of Public Health; Maternal, Child and Adolescent Health Division 2 CMQCC S California Maternal Quality Care Collaborative S Multidisciplinary Task Force S Recommendations/ Obstetric Safety Bundle S Yellow/Blue Slides Maternal Mortality Rates, Moving Average, California Residents; 1999-2010 16 14 14.0 12.2 13.5 13.2 12 12.7 11.6 12.1 11.5 10 9.4 10.2 8 6 4 Maternal Deaths per 100,000 Live Births 2 0 1999-2001 2000-2002 2001-2003 2002-2004 2003-2005 2004-2006 2005-2007 2006-2008 2007-2009 2008-2010 Three-Year Moving Average SOURCE: State of California, Department of Public Health, California Birth and Death Statistical Master Files, 1999-2010. Maternal mortality for California (deaths ≤ 42 days postpartum) was calculated using ICD-10 cause of death classification (codes A34, O00-O95,O98-O99) for 1999-2010. On average, the mortality rate increased by 2% each year [(95% CI: 1.0%, 4.2%) p=0.06. Poisson regression] for a statistically significant increasing trend from 1999-2010 (p=0.001 one-sided Cochran-Armitage, based on individual year data). Produced by California Department of Public Health, Center for Family Health, Maternal, Child and Adolescent Health Division, December, 2012. North Carolina: Mortality Mostly Preventable Cause of Death (n=108) % of All Deaths % Preventable Cardiomyopathy 21% 22% Hemorrhage 14 93 PIH 10 60 CVA 9 0 Chronic condition 9 89 AFE 7 0 Infection 7 43 Pulmonary embolism 6 17 Berg CJ, Harper MA, Atkinson SM, et al.